ZURICH/FRANKFURT (Reuters) - Shares in Actelion Ltd jumped as much as 19 percent to record highs on Friday on reports that U.S. healthcare company Johnson &amp; Johnson was interested in a takeover of the fast-growing Swiss biotechnology firm.<div><a href="http://feeds.reuters.com/~ff/reuters/technologyNews?a=VbVVIQz8ohg:s1MKZg5JlBI:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/reuters/technologyNews?d=yIl2AUoC8zA" border="0" /></a> <a href="http://feeds.reuters.com/~ff/reuters/technologyNews?a=VbVVIQz8ohg:s1MKZg5JlBI:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/reuters/technologyNews?i=VbVVIQz8ohg:s1MKZg5JlBI:V_sGLiPBpWU" border="0" /></a> <a href="http://feeds.reuters.com/~ff/reuters/technologyNews?a=VbVVIQz8ohg:s1MKZg5JlBI:-BTjWOF_DHI"><img src="http://feeds.feedburner.com/~ff/reuters/technologyNews?i=VbVVIQz8ohg:s1MKZg5JlBI:-BTjWOF_DHI" border="0" /></a></div><img src="http://feeds.feedburner.com/~r/reuters/technologyNews/~4/VbVVIQz8ohg" height="1" width="1" alt="" />